Answers are grounded in this paper and cite their sources.
Background/Objectives: Chest wall reconstruction following chest wall resection requires restoration of structural integrity while minimizing postoperative and prosthesis-related complications. Mesh materials are generally classified as either biologic or synthetic. Historically, chest wall reconstructions have prioritized mechanical durability, with synthetic meshes such as polytetrafluoroethylene (PTFE) or Gore-Tex commonly used due to their strength and impermeability. Strattice (Allergan Aesthetics, AbbVie company, Irvine, CA) a non-cross-linked porcine acellular dermal matrix, has been used as an alternative reconstructive material. Evidence regarding its outcomes in chest wall reconstruction remains limited. We describe our single-center experience using Strattice for chest wall reconstruction following chest wall resection. Methods: We retrospectively reviewed 56 patients who underwent chest wall resection and reconstruction with Strattice mesh between 2016 and 2024. Patient demographics, comorbidities, tumor characteristics, treatment history, and follow-up data were collected from EHR. Primary outcomes included postoperative complications, mesh related complications, and overall survival. Kaplan–Meier methods were used to estimate overall survival. Multivariable linear regression evaluated factors associated with hospital length of stay. Results: Mean follow-up was 2.9 ± 2.4 years. Estimated overall survival at 1, 3, and 5 years was 68.8%, 59.0%, and 49.0% respectively, with median overall survival 4.87 years (95% CI, 1.86-not estimable). On exploratory multivariable analysis, length of stay was longer among patients in the third neighborhood deprivation index (NDI) quartile relative to the lowest quartile (adjusted mean difference, 2.72 days, 95% CI, 0.88–4.56; p = 0.004), without a monotonic pattern across quartiles. This isolated finding should not be overinterpreted given the sample size and number of covariates tested. Return to the emergency department occurred in 14.3% of patients, atrial fibrillation in 10.7%, hospital readmission in 8.9%, and prolonged mechanical ventilation in 7.1%. Myocardial infarction and pneumonia occurred in 5.4% and 3.6% of patients, respectively, while wound infection was observed in one patient (1.8%). No patient required mesh explantation or replacement. Conclusions: In this retrospective case series, chest wall reconstruction with Strattice mesh was associated with a low observed rate of postoperative and mesh-related complications, with no documented mesh failures during available follow-up.
No takes yet. Share an insight, caveat, or question.
Vasic et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: